A Denver district judge has dismissed a lawsuit filed by Mammoth Farms, Colorado’s largest outdoor cannabis grower, against several state agencies regarding synthetic marijuana products. The ruling, made on May 15, 2025, stated that Mammoth Farms must pursue administrative channels rather than the courts to seek regulatory changes against these products.
The cannabis industry in Colorado, valued at over a billion dollars, faces various regulatory challenges, especially concerning synthetic marijuana, which remains classified as a Schedule I drug under federal law. Despite Colorado’s reputation as a pioneer in cannabis legalization, with recreational use approved in 2012, the landscape remains complex and fraught with issues.
Mammoth Farms, based in Saguache and owned by former military intelligence officer Justin Trouard, brought the lawsuit after discovering that customers were purchasing leftover cannabis trimmings and stems from their operations. Trouard’s investigation revealed that these materials were being used to produce illegal synthetic marijuana, commonly known as Spice or K2, by spraying chemicals onto plant matter. This practice allowed illegal producers to sell synthetic products at lower prices, undermining legal cannabis sales and impacting Mammoth’s profits.
After notifying the Colorado Marijuana Enforcement Division (MED) about these illegal activities, including the involvement of individuals with felony convictions, Trouard grew frustrated with the lack of action taken by the agency. As weeks turned into months without any response, he sought legal recourse, hoping to compel the state to enforce stricter regulations against synthetic marijuana.
However, Judge Jill Dorancy ruled that Mammoth Farms had not properly pursued the necessary administrative steps to request new rules from the MED. The court emphasized that the company should engage with the regulatory process instead of seeking immediate judicial intervention. According to the Colorado Administrative Procedure Act, Mammoth’s legal claims were deemed moot since no formal request for regulatory changes had been submitted.
While Mammoth may still find a path to address its concerns through the proper administrative channels, the timeline for achieving any regulatory changes remains uncertain. The MED has expressed its intent to eliminate dangerous products from dispensaries, which may align with Mammoth’s objectives, but the process of rulemaking can be lengthy.
This case highlights the ongoing challenges within the cannabis industry, where regulatory frameworks struggle to keep pace with evolving products and practices. As the industry continues to grow, the need for clear and effective regulation becomes increasingly critical to ensure consumer safety and fair market competition.
English 
Spanish 
German 
Czech